Hemophilia A epidemiology and demographics

Jump to navigation Jump to search

Hemophilia A Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemophilia A from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemophilia A epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemophilia A epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemophilia A epidemiology and demographics

CDC on Hemophilia A epidemiology and demographics

Hemophilia A epidemiology and demographics in the news

Blogs on Hemophilia A epidemiology and demographics

Directions to Hospitals Treating Hemophilia A

Risk calculators and risk factors for Hemophilia A epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Fahd Yunus, M.D. [2] Vahid Eidkhani, M.D.

Overview

The incidence of Hemophilia A is approximately 1 per 5,000 to 10,000 males worldwide. In 2016, it was estimated that 20,000 males in the United States were living with Hemophilia A.[1]

In contrast, Hemophilia B is a much rarer disease affecting 1 in 30,000 males worldwide.

Hemophilia C is a much rarer disease affecting only 1:1,000,000 individuals but it is more frequent among Ashkenazi Jews (1:450 individuals)[2].

Epidemiology and Demographics

Age
Patients of all age groups may present with hemophilia A and B. Patients with more severe disease (i.e. greater deficiency in Factor VIII/IX) present earlier(usually neonatal or infantile period) than those with only mild disease. Acquired hemophilia usually presents in middle-aged or elderly individuals, as well as in females in the peri-partum period[3].
Gender
As Hemophilia A and B inheritance is linked to chromosome X and the gene is recessive, the disease mainly appears in males as they have only one X chromosome and the penetrance is 100%. In rare cases, females heterozygous for the condition may present with features of the disease, due to random X-inactivation or lyonization or patients with Turner syndrome. Hemophilia C is an autosomal disease and its incidence is not gender dependent[4].
Race
There is no racial predilection for Hemophilia A and B.[5]

References

  1. What is Hemophilia? – NHLBI, NIH. Available at http://www.nhlbi.nih.gov/health/health-topics/topics/hemophilia. Accessed on Sept 20, 2016
  2. Shpilberg O, Peretz H, Zivelin A, Yatuv R, Chetrit A, Kulka T; et al. (1995). "One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews". Blood. 85 (2): 429–32. PMID 7811996.
  3. Kessler CM, Knöbl P (2015). "Acquired haemophilia: an overview for clinical practice". Eur J Haematol. 95 Suppl 81: 36–44. doi:10.1111/ejh.12689. PMID 26679396.
  4. Duga S, Salomon O (2013). "Congenital factor XI deficiency: an update". Semin Thromb Hemost. 39 (6): 621–31. doi:10.1055/s-0033-1353420. PMID 23929304.
  5. Data & Statistics | Hemophilia | NCBDDD | CDC. Available at http://www.cdc.gov/ncbddd/hemophilia/data.html Accessed on July 30,2016

Template:WH Template:WS